These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 6885343)

  • 1. Effect of continuous ambulatory peritoneal dialysis on anemia in uremic patients.
    Marcovici O; Boner G; Rosenfeld JB
    Isr J Med Sci; 1983 Jul; 19(7):604-7. PubMed ID: 6885343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of phospholipids asymmetry in red blood cells contributes to anemia in uremic patients.
    Kong QY; Wu X; Li J; Peng WX; Ye R; Lindholm B; Wang T
    Adv Perit Dial; 2001; 17():58-60. PubMed ID: 11510298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone contributes to variations in blood morphology in diabetic and non diabetic patients treated with continuous ambulatory peritoneal dialysis.
    Grzegorzewska AE; Mariak I
    Adv Perit Dial; 2001; 17():5-9. PubMed ID: 11510296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anemia in patients on continuous ambulatory peritoneal dialysis (CAPD)].
    Tokuda Y; Itou H; Uchida Y; Azuma K; Ohtsuka H; Uomizu K; Yamashita W; Harada R; Nakashima A; Morita T
    Fukuoka Igaku Zasshi; 1989 Jul; 80(7):379-84. PubMed ID: 2807127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
    Raja R; Bloom E; Johnson R; Goldstein M
    Adv Perit Dial; 1994; 10():135-8. PubMed ID: 7999811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What happens after conversion of treatment to continuous ambulatory peritoneal dialysis from hemodialysis?
    Sezer S; Ozdemir N; Arat Z; Güz G; Sengül S; Akman B; Haberal A; Turan M; Haberal M
    Adv Perit Dial; 2000; 16():177-81. PubMed ID: 11045288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure.
    McGonigle RJ; Wallin JD; Husserl F; Deftos LJ; Rice JC; O'Neill WJ; Fisher JW
    J Lab Clin Med; 1984 Dec; 104(6):1016-26. PubMed ID: 6501997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients.
    Raja R; Bloom E; Johnson R
    Adv Perit Dial; 1993; 9():177-80. PubMed ID: 8105918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of erythrocytes phosphatidylserine exposure in anemia in peritoneal dialysis patients.
    Bi SH; Cheng LT; Wang T
    Ren Fail; 2006; 28(7):573-6. PubMed ID: 17050240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
    Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
    J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin and uremic toxicity during continuous ambulatory peritoneal dialysis.
    Wideröe TE; Sanengen T; Halvorsen S
    Kidney Int Suppl; 1983 Dec; 16():S208-17. PubMed ID: 6588251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patients.
    Canavese C; Grill A; Decostanzi E; Maddalena E; Barbieri S; Martina G; Fop F; Buglione E; Grechi D; David O; Saitta M; Piccoli G
    Clin Nephrol; 2000 Jan; 53(1):42-7. PubMed ID: 10661481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acid-base equilibrium in uremia: effect of continuous ambulatory peritoneal dialysis and hemodialysis].
    Nin Ferrari J; Santoro A; Fabbri L; Cavilli F; Zucchelli P
    G Clin Med; 1981 Sep; 62(9):624-33. PubMed ID: 7319174
    [No Abstract]   [Full Text] [Related]  

  • 16. [A study of anemia in 86 patients on hemodialysis (author's transl)].
    Serra A; Camps J; Morlans M; Olmos A; Carrera A; Soriano B; Rodríguez JA; Pelegrí A; Bartolomé J; Piera L
    Med Clin (Barc); 1981 May; 76(10):439-43. PubMed ID: 7242164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infrequent dosing of subcutaneous erythropoietin for the treatment of anemia in patients on CAPD.
    Bunke M; Bartlett DK; Brier ME; Golper TA
    Adv Perit Dial; 1993; 9():331-5. PubMed ID: 8105957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation, peritoneal transport, and response to erythropoietin in peritoneal dialysis patients.
    Pilkey RM; Morton AR; Iliescu EA
    Adv Perit Dial; 2001; 17():153-7. PubMed ID: 11510266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with subcutaneous erythropoietin in CAPD patients.
    Bailie GR; Plitnick R; Eisele G; Clement C; Rasmussen R
    Adv Perit Dial; 1991; 7():292-5. PubMed ID: 1680449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autonomic function in uremic patients treated by hemodialysis or CAPD and in transplant patients.
    Mallamaci F; Zoccali C; Ciccarelli M; Briggs JD
    Clin Nephrol; 1986 Apr; 25(4):175-80. PubMed ID: 3516480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.